| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The incise drape is the first to feature Avery Dennison's patented BeneHold™ CHG adhesive technology DUBLIN, Ohio, March 17, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched the...
Read more about New Cardinal Health surgical drape helps reduce surgical site contamination risk
46 of 49 Eligible States and Over 90 Percent of Litigating Political Subdivisions Participate CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC),...
Read more about Distributors Approve Opioid Settlement Agreement
Today Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, and Cardinal Health (NYSE: CAH) announced expanded distribution of Cue's professional use and over-the-counter COVID-19...
Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more,...
Read more about Cardinal Health named one of America's Best Large Employers 2022 by Forbes magazine
Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain agility. Kinaxis will enhance Cardinal...
Read more about Cardinal Health partners with Kinaxis to optimize digital supply chain planning
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer...
Read more about Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in the U.S.
Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year. Second quarter GAAP operating loss was...
Read more about Cardinal Health Reports Second Quarter Fiscal 2022 Results
Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response (GMR) and Cardinal Health who will each...
Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting...
Read more about Cardinal Health Provides Medical Segment Fiscal Year 2022 Financial Update
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company...
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...
Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...
Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...
Read more about Cardinal Health's WaveMark™ launches supply automation solution for clinical labs
Kannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...
Read more about Cardinal Health Reports First Quarter Fiscal 2022 Results
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...
Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...
Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...
Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its launch. In October last year, the...
Read more about Business solutions for the next public health emergency
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an...
Read more about Distributors Announce Settlement With Cherokee Nation
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange. The company will...
DUBLIN, Ohio—Cardinal Health (NYSE: CAH) today launched the Reimbursement Solution—a comprehensive approach designed to help hospitals and health systems minimize their number of claim...
Read more about Cardinal Health reinvents hospital claims remittance with comprehensive approach